Clinical remission in severe asthma with biologic therapy: an analysis from the UK Severe Asthma Registry

Abstract

18.3% of patients achieved the primary definition of clinical remission. Remission was more likely in T2-high biomarker patients with shorter duration of disease and less comorbidity. Further research on the optimum time to commence biologics in severe asthma is required.